Inception Return
(10/16/2020)
|
3.66 %
|
|
YTD Return
|
6.84 %
|
|
NAVPS
(6/27/2025)
|
$10.23
|
|
Change
|
$0.12 / 1.23 %
|
|
|
Growth of $10,000
(As of May 31, 2025)
|
|
MER
|
1.48 %
|
|
Assets ($mil)
|
$400.04
|
|
Rank (1Yr)
|
174/193
|
|
Std Dev (3Yr)
|
-
|
|
Volatility Ranking (3Yr)
|
10/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
No Load
|
|
Max Front End
|
-
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
The Fund aims to provide long-term capital appreciation by investing primarily in long and short positions of equity securities of companies anywhere in the world. The Fund may use leverage through the use of short selling of up to 50% of its net asset value and by investing in derivatives. The Fund’s gross exposure shall not exceed the limits on the use of leverage or as otherwise permitted under applicable securities legislation and/or regulatory approval.
|
Fund Manager
Fidelity Investments Canada ULC
Portfolio Manager
Daniel Dupont, Fidelity Investments Canada ULC
Sub-Advisor
Fidelity Canada Investment Management
|
|
Asset Allocation
(As of March 31, 2025)
|
Sector Allocation
(As of March 31, 2025)
|
Geographic Allocation
(As of March 31, 2025)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| U.S. DOLLAR | Cash and Equivalents | Cash and Cash Equivalent | United States | 26.89% |
| Fidelity U.S. Money Market Investment Trust O | Cash and Equivalents | Cash and Cash Equivalent | United States | 19.61% |
| Imperial Brands PLC | International Equity | Consumer Goods | European Union | 4.69% |
| British American Tobacco PLC | International Equity | Consumer Goods | European Union | 4.21% |
| Bayer AG Cl N | International Equity | Healthcare | European Union | 3.88% |
| Diageo PLC | International Equity | Consumer Goods | European Union | 3.70% |
| Nestle SA Cl N | International Equity | Consumer Goods | Other European | 3.68% |
| Metro Inc | Canadian Equity | Consumer Services | Canada | 3.52% |
| Dollar Tree Inc | US Equity | Consumer Services | United States | 3.24% |
| Johnson & Johnson | US Equity | Healthcare | United States | 3.20% |
Performance Data
(As of May 31, 2025)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-8.75
|
-1.31
|
9.48
|
6.84
|
-5.75
|
-6.87
|
-
|
-
|
|
Benchmark
|
5.56
|
3.87
|
3.54
|
7.05
|
21.05
|
11.55
|
14.92
|
8.99
|
|
Quartile Ranking
|
4
|
3
|
1
|
1
|
4
|
4
|
-
|
-
|
|
Calendar Return (%)
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
|
Fund
|
-16.49
|
-27.99
|
68.11
|
1.46
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Benchmark
|
21.65
|
11.75
|
-5.84
|
25.09
|
5.60
|
22.88
|
-8.89
|
9.10
|
21.08
|
-8.32
|
|
Quartile Ranking
|
4
|
4
|
1
|
4
|
-
|
-
|
-
|
-
|
-
|
-
|